Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.

MLA

Silpa-Archa, Sukhum, et al. “Outcome of Tocilizumab Treatment in Refractory Ocular Inflammatory Diseases.” Acta Ophthalmologica, vol. 94, no. 6, Sept. 2016, pp. e400–06. EBSCOhost, https://doi.org/10.1111/aos.13015.

APA

Silpa-Archa, S., Oray, M., Preble, J. M., & Foster, C. S. (2016). Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmologica, 94(6), e400–e406. https://doi.org/10.1111/aos.13015

Chicago

Silpa-Archa, Sukhum, Merih Oray, Janine M Preble, and Charles Stephen Foster. 2016. “Outcome of Tocilizumab Treatment in Refractory Ocular Inflammatory Diseases.” Acta Ophthalmologica 94 (6): e400–406. doi:10.1111/aos.13015.